Keywords
Abstract
The study was conducted in servicemen diagnosed with coxarthrosis of the hip joint and osteonecrosis of the femoral head. These dystrophic and degenerative diseases were detected on X-rays. Those in the study were divided into 3 age groups: 18-29 years old, 30-44 years old and 45 and older. In order to determine the antioxidant protection activity of the organism, the ceruloplasmin index was studied. The average value of ceruloplasmin was higher in patients with coxarthrosis and osteonecrosis than in healthy individuals. This value was found to be 24.3% lower than the value in osteonecrosis in the control group (р <0.05). When the patients were studied by gender, the following was found: male patients with osteonecrosis of the femoral head and men in the control group had a significant difference in this value (р <0.05). In conclusion, ceruloplasmin is a biological marker that shows the body's antioxidant protection in dystrophic and degenerative changes of the hip joint (coxarthrosis of the hip joint and osteonecrosis of the femoral head).
References
Bakhautdin B., Goksoy B. E., Fox P. L. Ceruloplasmin has two nearly identical sites that bind myeloperoxidase. Biochem Biophys Res Commun., 2014. - N 453(4). - Р. 722-727. doi: 10.1016/j.bbrc.2014.09.134.
Bayjanov A. K., Muxitdinova I. R., Ibragimova N. X. Selected laboratory parameters for COVID-19-associated aseptic necrosis of the hip joint in military personnel / Multidiscipline Proceedings of "DIGITAL FASHION CONFERENCE", Korea, November, 2023. - Volume 3, - N 6. – р. 7-8. https://www.digitalfashionsociety.org/index.php/conference/article/view/214/210
Bonaccorsi M. C., Cutone A., Polticelli F. et al. The ferroportin-ceruloplasmin system and the mammalian iron homeostasis machine: regulatory pathways and the role of lactoferrin // Biometals., 2018. - N 31(3). - Р. 399-414. doi: 10.1007/s10534-018-0087-5.
Corradini E., Buzzetti E., Dongiovanni P. et al. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD / J Hepatol., 2021. - N 75(3). - Р. 506-513. doi: 10.1016/j. jhep.2021.03.014
Das S., Sahoo P. K. Ceruloplasmin, a moonlighting protein in fish / Fish Shellfish Immunol., 2018. - N82. - Р. 460-468.
Golizeh M., Lee K., Ilchenko S. et al. Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes. Free Radic Biol Med., 2017. - N 113. - Р. 461-469. doi: 10.1016/j.freerad biomed.2017.10.373.
Golenkina E. A., Viryasova G. M., Galkina S. I. et al. Fine regulation of neutrophil oxidative status and apoptosis by ceruloplasmin and its derivatives // Cells., 2018. - N 7(1). doi: 10.3390/cells7010008.
Lee M. J., Jung C. H., Kang Y. M. et al. Serum ceruloplasmin level as a predictor for the progression of diabetic nephropathy in Korean men with Type 2 diabetes mellitus // Diabetes Metab J., 2015. - N39(3). - Р. 230-239. doi: 10.4093/dmj.2015.39.3.230.
Mukhopadhyay B. P. Insights from molecular dynamics simulation of human ceruloplasmin (ferroxidase enzyme) binding with biogenic monoamines. Bioinformation., 2019. - N15(10). - Р. 750-759. doi: 10.6026/973200015750.
Mukhopadhyay B. P. Putative role of conserved water molecules in the hydration and inter-domain recognition of mono nuclear copper centers in O2-bound human ceruloplasmin: a comparative study between X-ray and MD simulated structures / Bioinformation., 2019. - N 15(6). - Р. 402-411. doi: 10.6026/97320630015402
Musci G., Polticelli F., Bonaccorsi P. C. Ceruloplasmin-ferroportin system of iron traffic in vertebrates / World J Biol Chem., 2014. - N 5(2). - Р. 204-215. doi: 10.4331/wjbc.v5.i2.204.
Pelucchi S., Ravasi G., Piperno A. Ceruloplasmin variants might have different effects in different iron overload disorders / J Hepatol., 2021. - N 75(4). - Р. 1003-1004. doi: 10.1016/j.jhep.2021.05.005.
Ramos D., Mar D., Ishida M. et al. Mechanism of copper uptake from blood plasma ceruloplasmin by mammalian cells. PLoS One., 2016. - N 11(3). - Р. 149-516. doi: 10.1371/journal.pone.0149516.
Siotto M., Simonelli I., Pasqualetti P. et al. Association between serum ceruloplasmin specific activity and risk of Alzheimer's disease / J Alzheimers Dis., 2016. - N 50(4). - Р. 1181-1189. doi: 10.3233/JAD-150611.
Sokolov A. V., Zakharova E. T., Kostevich V. A. et al. Lactoferrin, myeloperoxidase, and ceruloplasmin: complementary gearwheels cranking physiological and pathological processes / Biometals., 2014. - N 27(5). - Р. 815-828. doi: 10.1007/s10534-014-9755-2.
Tian S., Jones S. M., Jose A. et al. Chloride control of the mechanism of human serum ceruloplasmin (Cp) catalysis / J Am Chem Soc., 2019. - N 141(27). - Р. 10736-10743. doi: 10.1021/jacs.9b03661.
Vlasova I. I., Sokolov A. V., Kostevich V.A. et al. Myeloperoxidase-Induced Oxidation of Albumin and Ceruloplasmin: Role of Tyrosines / Biochemistry (Mosc)., 2019. - N 84(6). - Р. 652-662.